Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

172.21
Delayed Data
As of Oct 19
 -0.74 / -0.43%
Today’s Change
95.14
Today|||52-Week Range
175.72
+52.83%
Year-to-Date

Today’s Trading

Previous close172.95
Today’s open173.00
Day’s range170.57 - 173.37
Volume225,788
Average volume (3 months)290,319
Market cap$7.6B
Dividend yield--
Data as of 3:59pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+85.64%
Earnings growth (next 5 years)+40.50%
Revenue growth (last year)+35.13%
P/E ratio101.3
Price/Sales12.56
Price/Book16.71

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+0.03+0.07%
WSTWest Pharmaceutical ...-0.13-0.14%
MASIMasimo Corp-0.77-0.89%
IARTIntegra LifeSciences...+0.38+0.75%
Data as of 4:02pm ET, 10/19/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts